लोड हो रहा है...
Regulatory and clinical considerations for biosimilar oncology drugs
Biological oncology products are integral to cancer treatment, but their high costs pose challenges to patients, families, providers, and insurers. The introduction of biosimilar agents—molecules that are similar in structure, function, activity, immunogenicity, and safety to the original biological...
में बचाया:
| में प्रकाशित: | Lancet Oncol |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , , , , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2014
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404762/ https://ncbi.nlm.nih.gov/pubmed/25456378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)70365-1 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|